Report Library
All Reports
JP Morgan 2018 - Day 4
January 11, 2018
The 36th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 8-11, 2018. A list of events and catalysts that were announced or updated at the conference today is included in this report.
Highlights from today’s company presentations are included for:
Mid Cap
For the full report, please download the PDF version at the top of this page.
For our disclosures, please read the Biomedtracker Research Standards.
Highlights from today’s company presentations are included for:
Mid Cap
- Immunomedics (IMMU)
- TG Therapeutics (TGTX)
- Vifor Pharma (VIFN; Galenica)
- NewLink Genetics (NLNK)
- Seres Therapeutics (MCRB)
- MacroGenics (MGNX)
- AVEO Oncology (AVEO)
- Retrophin (RTRX)
- CymaBay (CBAY)
- Dynavax (DVAX)
- Otonomy (OTIC)
- Syros (SYRS)
- aTyr (LIFE)
For the full report, please download the PDF version at the top of this page.
For our disclosures, please read the Biomedtracker Research Standards.
| Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine ENT/Dental Gastroenterology (Non Inflammatory Bowel Disease) Hematology Infectious Disease Metabolic Neurology Not Specified Obstetrics/Gynecology Oncology Ophthalmology Orthopedics Psychiatry Renal Respiratory Rheumatology (Non Autoimmune) Urology |
Additional Resources: